DEF 14A: Retractable Technologies Sets Date for 2024 Annual Shareholder Meeting, Director Elections on the Agenda

Retractable Technologies, Inc. will hold its 2024 virtual Annual Meeting of Shareholders on May 10, 2024, to elect three Class 2 Directors.

Summary

• Retractable Technologies, Inc. is holding its virtual Annual Meeting of Shareholders on May 10, 2024.
• Shareholders will vote on the election of three Class 2 Directors: Thomas J. Shaw, Walter O. Bigby, Jr., and John W. Fort III.
• The Board of Directors recommends voting 'For All' nominees.
• The record date for determining shareholders eligible to vote is March 11, 2024.
• Shareholders can vote online, by mail, by phone, or during the virtual meeting.
• The company's Board of Directors is comprised of six members divided into two classes.
• The proxy statement details corporate governance practices, including the roles of the Audit, Compensation and Benefits, and Nominating Committees.
• The company's executive compensation program aims to attract, retain, and motivate highly qualified executive officers.
• The company has selected Moss Adams LLP as its independent accountants for the year ending December 31, 2024.
• Shareholder proposals for the 2025 Annual Meeting must be received by November 30, 2024.

Sentiment

Score: 6

Explanation: The document is a standard proxy statement, so the sentiment is neutral. It contains routine information about the annual meeting, director elections, and corporate governance. The mention of past option terminations and market challenges slightly lowers the score.

Positives

• The Board of Directors has established standing Audit, Compensation and Benefits, and Nominating Committees, each with a written charter available on the company's website.
• The company has a Code of Business Conduct and Ethics in place, designed to deter wrongdoing and promote ethical conduct.
• The company has a Disclosure Representative Policy to facilitate communication between shareholders and the Board of Directors.
• The Audit Committee reviews and approves all related party transactions.
• The company offers a 401(k) plan to all employees.

Negatives

• Executive compensation is not based on specific, quantitative corporate objectives.
• The company acknowledges that its stock price does not adequately reflect its performance.
• The company terminated outstanding but non-vested stock option awards to executive officers in December 2022 because they were significantly underwater.
• The company's pay ratio shows a significant disparity between the CEO's compensation and the median employee compensation.

Risks

• The company competes in a market environment where significant achievement or performance is not always correlated with corporate results.
• The company's ability to grow has been constrained by larger market players.
• Ongoing litigation and the competitive environment are principal factors influencing the company's operating results.
• The company's executive compensation program relies heavily on base salaries rather than incentive compensation due to market access constraints.
• The company's founder, Thomas J. Shaw, has significant control over the company due to his majority ownership, which could influence shareholder votes.

Future Outlook

The document outlines the procedures for shareholder proposals for the 2025 Annual Meeting, indicating a continuation of corporate governance processes.

Management Comments

• Thomas J. Shaw believes it is appropriate for him to continue to serve as a Director and as the Chairman of the Board because of his deep knowledge of the strengths and weaknesses of our products and of the Company.
• Management establishes the initial recommendations regarding compensation for all employees.
• Changes in the amount and/or form of compensation to executive officers are not generally pursued unless first proposed by Management.

Industry Context

The document does not provide specific details on how this announcement relates to broader industry trends or competitors, but it mentions the company competes in a market environment constrained by larger players.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards.
• It mentions the Dow Jones US Select Medical Equipment Index (DJSMDQ) as a peer group for pay versus performance analysis, but does not offer detailed comparisons.
• Without more specific data, it's difficult to assess Retractable Technologies' performance against industry benchmarks.

Related Party Transactions

• Thomas J. Shaw, President, Chief Executive Officer, and shareholder holding more than 5% of the outstanding Common Stock, contracted with us under the Technology Licensing Agreement for the exclusive worldwide licensing rights to manufacture, market, sell, and distribute retractable medical safety products.
• A royalty of 5% of gross sales of all licensed products sold to customers over the life of the Technology Licensing Agreement is paid.
• Royalties of $3,191,276 and $8,414,090 were paid to Mr. Shaw in 2023 and 2022, respectively.
• As of March 11, 2024, $800,000 relating to 2023 sales have been paid to Mr. Shaw during 2024.

Stakeholder Impact

• Shareholders have the opportunity to vote on the election of directors and influence the company's governance.
• Employees are impacted by the company's compensation policies and benefit plans.
• The company's performance and strategic decisions affect its customers and suppliers.

Next Steps

• Shareholders are encouraged to vote on the election of directors.
• The company will hold its virtual Annual Meeting on May 10, 2024.
• Shareholders can submit proposals for the 2025 Annual Meeting by the specified deadlines.

Key Dates

Keywords

annual meeting, proxy statement, directors, shareholders, compensation, governance, voting, Retractable Technologies, RVP